FDA Report: Take Avandia Off the Market
Two officials from the Food and Drug Administration are recommending that diabetes drug Avandia be pulled from the market because of its potential to harm the heart, the New York Times reports. Agency reports suggest that if every diabetic taking Avandia switched to a different medication, about 500 heart attacks would be averted each month. And in the third quarter of 2009, Avandia was linked to 304 deaths, the Times reports. Avandia’s heart risks came to light following a 2007 study by the Cleveland Clinic, but later studies failed to show a definitive link. An FDA advisory committee is being assembled to assess whether or not Avandia should continue to be sold.
Sorry, the comment form is closed at this time.